JPWO2020246535A1 - - Google Patents
Info
- Publication number
- JPWO2020246535A1 JPWO2020246535A1 JP2021524895A JP2021524895A JPWO2020246535A1 JP WO2020246535 A1 JPWO2020246535 A1 JP WO2020246535A1 JP 2021524895 A JP2021524895 A JP 2021524895A JP 2021524895 A JP2021524895 A JP 2021524895A JP WO2020246535 A1 JPWO2020246535 A1 JP WO2020246535A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019105453 | 2019-06-05 | ||
PCT/JP2020/022065 WO2020246535A1 (en) | 2019-06-05 | 2020-06-04 | Htlv-i-specific ctl activator |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2020246535A1 true JPWO2020246535A1 (en) | 2020-12-10 |
Family
ID=73653235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021524895A Pending JPWO2020246535A1 (en) | 2019-06-05 | 2020-06-04 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2020246535A1 (en) |
WO (1) | WO2020246535A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004092373A1 (en) * | 2003-04-16 | 2004-10-28 | Japan Science And Technology Agency | Peptide having htlv-1-specific ctl-inducing activity |
WO2006035681A1 (en) * | 2004-09-27 | 2006-04-06 | National University Corporation Tokyo Medical And Dental University | HLA-A11-RESTRICTED Tax ANTITUMOR EPITOPES |
JP2012090574A (en) * | 2010-10-27 | 2012-05-17 | St Marianna Univ School Of Medicine | METHOD FOR PRODUCING γδT-CELL, AND PHARMACEUTICAL |
JP2016077185A (en) * | 2014-10-14 | 2016-05-16 | 学校法人 聖マリアンナ医科大学 | PRODUCTION METHOD AND MEDICINE OF γδT CELLS |
-
2020
- 2020-06-04 WO PCT/JP2020/022065 patent/WO2020246535A1/en active Application Filing
- 2020-06-04 JP JP2021524895A patent/JPWO2020246535A1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2020246535A1 (en) | 2020-12-10 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230602 |